All posts by: Michael Zand

About Michael Zand

Protein Libraries Pave the Way for New Treatment Options – R & D Magazine

Continue reading

2017-07-25 NEWS

Protein Libraries Pave the Way for New Treatment Options
R & D Magazine
“Our vision is to apply the same approach but rapidly screen non-synthetic, biological or ‘natural’ molecules cloned from human or other genomes, including those of plants, animals and microbes,” Parekkadan said. “This could transform pharmaceutical

Continue reading

2017-07-25 NEWS

Protein Libraries Pave the Way for New Treatment Options
R & D Magazine
“Our vision is to apply the same approach but rapidly screen non-synthetic, biological or ‘natural’ molecules cloned from human or other genomes, including those of plants, animals and microbes,” Parekkadan said. “This could transform pharmaceutical

Continue reading

2017-07-25 NEWS

Wall Street Journal (subscription)

Crispr: Both Vishnu and Shiva—Preserver, Destroyer
Wall Street Journal (subscription)
Even before Crispr technology, there were national security concerns that malicious state actors (North Korea, Iran, Russia, China) or terrorists could bioengineer a virus or a bacteria to be more lethal and easier to transmit. With Crispr, the

Continue reading

2017-07-25 NEWS

Shedding light on cause of resistance to tumor immunotherapy
Medical Xpress
In tumor immunotherapy, the body’s own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used. Researchers at the University of Zurich and the University

and more »